Supplements

Guidelines supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs. Our range includes Guidance Update, Product Review, and Guidelines Handbook

Index image

Hormone replacement therapy (HRT) shortage: switching to Femoston® (estradiol/dydrogesterone) from an alternative combination oral or transdermal HRT

2019-12-19T08:31:00+00:00Commissioned by Mylan

Information for healthcare professionals only.

Guidance update - Asthma and Sirdupla

Asthma guidance update

2019-10-24T08:48:00+01:00Commissioned by Mylan

This Guidelines supplement has been commissioned and funded by Mylan and developed in partnership with Guidelines. The content on page 3 was commissioned by Mylan and Mylan has carried out full medical review and approval to ensure compliance. See page 2 for full disclaimer.

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

2019-08-02T07:39:00+01:00Funded by Mylan

Information intended for healthcare professionals only.

sign diabetes supplement

Type 2 diabetes: an overview of the SIGN guideline on pharmacological management of glycaemic control

2018-08-16T10:10:00+01:00Funded by Napp Pharmaceuticals Limited

Production of this Guidelines supplement has been funded by an educational grant from Napp Pharmaceuticals Limited. The grant included an honorarium for the author. Napp Pharmaceuticals Limited has reviewed the supplement for technical accuracy and to ensure compliance with regulations. Napp Pharmaceuticals Limited has had no input into or ...


Validate Accessibility